Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Notes Payables (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Notes Payables data on record, last reported at $4.1 million in Q4 2025.

  • For Q4 2025, Notes Payables rose 19.67% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, up 19.67%, while the annual FY2025 figure was $4.1 million, 19.67% up from the prior year.
  • Notes Payables reached $4.1 million in Q4 2025 per TCNNF's latest filing, down from $112.8 million in the prior quarter.
  • Across five years, Notes Payables topped out at $121.8 million in Q4 2023 and bottomed at $2.0 million in Q1 2021.
  • Average Notes Payables over 5 years is $34.7 million, with a median of $9.5 million recorded in 2022.
  • The widest YoY moves for Notes Payables: up 1214.55% in 2024, down 97.2% in 2024.
  • A 5-year view of Notes Payables shows it stood at $10.1 million in 2021, then rose by 23.89% to $12.5 million in 2022, then surged by 877.7% to $121.8 million in 2023, then tumbled by 97.2% to $3.4 million in 2024, then grew by 19.67% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $4.1 million in Q4 2025, $112.8 million in Q3 2025, and $113.7 million in Q2 2025.